Monoclonal Antibodies against SARS-CoV-2: Potential Game-Changer Still Underused
Even several months after the start of a massive vaccination campaign against COVID-19, mortality and hospital admission are still high in many countries. Monoclonal antibodies against SARS-CoV-2 are the ideal complement to vaccination in infected subjects who are at high risk for progression to sev...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/b7fb01da7b214bbf9105986b0f8ace84 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!